2020
Stem Cell Therapy for Thromboangiitis Obliterans (Buerger’s Disease)
Dash B, Peyvandi H, Duan K, Richardson E, Ndon S, Gabrick K, Faz A, Persing J, Dardik A, Hsia H. Stem Cell Therapy for Thromboangiitis Obliterans (Buerger’s Disease). Processes 2020, 8: 1408. DOI: 10.3390/pr8111408.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsThromboangiitis obliteransYoung male smokersBuerger's diseaseImmunomodulatory approachesMale smokersSurgical bypassPathological findingsTreatment modalitiesVascular diseaseDefinitive cureLower extremitiesMedium arteriesLesion treatmentTherapeutic modalitiesTAO treatmentTherapeutic angiogenesisCell therapyDiseaseObliteransStem cellsCurrent knowledgeModalitiesTreatmentPotential optionVasculitis
1989
The Craniofacial Resection—Eleven‐Year Experience at the University of Virginia: Problems and Solutions
Levine P, Scher R, Jane J, Persing J, Newman S, Miller J, Cantrell R. The Craniofacial Resection—Eleven‐Year Experience at the University of Virginia: Problems and Solutions. Otolaryngology 1989, 101: 665-669. PMID: 2512555, DOI: 10.1177/019459988910100609.Peer-Reviewed Original ResearchConceptsVirginia Health Sciences CenterMedial canthal ligamentHealth Sciences CenterUnderwent repeatRecurrent diseaseExtended resectionNeurologic problemsSignificant complicationsCavernous sinusCraniofacial resectionSurgical techniqueLacrimal sacCanthal ligamentPatientsYears' experienceResectionComplicationsUniversity of VirginiaEsthesioneuroblastomaScience CenterSurgerySinusTumorsInfectionDiseaseMultiple sclerosis and brain tumor: A diagnostic challenge
Paley R, Persing J, Doctor A, Westwater J, Roberson J, Edlich R. Multiple sclerosis and brain tumor: A diagnostic challenge. Journal Of Emergency Medicine 1989, 7: 241-244. PMID: 2545771, DOI: 10.1016/0736-4679(89)90353-3.Peer-Reviewed Original Research